US4072565A
(en)
|
1974-11-04 |
1978-02-07 |
The Dow Chemical Company |
Production of viruses in tissue culture without use of serum
|
US3883511A
(en)
|
1974-03-07 |
1975-05-13 |
Rit Rech Ind Therapeut |
New 6-aminopenicillanic acid derivative
|
USRE30985E
(en)
|
1978-01-01 |
1982-06-29 |
|
Serum-free cell culture media
|
US4419446A
(en)
|
1980-12-31 |
1983-12-06 |
The United States Of America As Represented By The Department Of Health And Human Services |
Recombinant DNA process utilizing a papilloma virus DNA as a vector
|
NZ201705A
(en)
|
1981-08-31 |
1986-03-14 |
Genentech Inc |
Recombinant dna method for production of hepatitis b surface antigen in yeast
|
EP0082974B1
(en)
|
1981-12-24 |
1986-05-14 |
Asahi Kasei Kogyo Kabushiki Kaisha |
Method for the cultivation of normal diploid cells and cultivation medium used therefor
|
US4601978A
(en)
|
1982-11-24 |
1986-07-22 |
The Regents Of The University Of California |
Mammalian metallothionein promoter system
|
US4560655A
(en)
|
1982-12-16 |
1985-12-24 |
Immunex Corporation |
Serum-free cell culture medium and process for making same
|
US4657866A
(en)
|
1982-12-21 |
1987-04-14 |
Sudhir Kumar |
Serum-free, synthetic, completely chemically defined tissue culture media
|
FR2543158B1
(fr)
|
1983-03-24 |
1985-11-15 |
Inst Nat Sante Rech Med |
Milieu de culture de cellules animales sans serum, sans hormones et sans facteurs de croissance et procedes de culture primaire et d'obtention de lignees cellulaires utilisant ce milieu
|
US4816567A
(en)
|
1983-04-08 |
1989-03-28 |
Genentech, Inc. |
Recombinant immunoglobin preparations
|
US4767704A
(en)
|
1983-10-07 |
1988-08-30 |
Columbia University In The City Of New York |
Protein-free culture medium
|
US4965199A
(en)
|
1984-04-20 |
1990-10-23 |
Genentech, Inc. |
Preparation of functional human factor VIII in mammalian cells using methotrexate based selection
|
US4879231A
(en)
|
1984-10-30 |
1989-11-07 |
Phillips Petroleum Company |
Transformation of yeasts of the genus pichia
|
GB8516415D0
(en)
|
1985-06-28 |
1985-07-31 |
Celltech Ltd |
Culture of animal cells
|
US4676980A
(en)
|
1985-09-23 |
1987-06-30 |
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Target specific cross-linked heteroantibodies
|
US4927762A
(en)
|
1986-04-01 |
1990-05-22 |
Cell Enterprises, Inc. |
Cell culture medium with antioxidant
|
GB8610600D0
(en)
|
1986-04-30 |
1986-06-04 |
Novo Industri As |
Transformation of trichoderma
|
IL87737A
(en)
|
1987-09-11 |
1993-08-18 |
Genentech Inc |
Method for culturing polypeptide factor dependent vertebrate recombinant cells
|
EP0308936B1
(en)
|
1987-09-23 |
1994-07-06 |
Bristol-Myers Squibb Company |
Antibody heteroconjugates for the killing of HIV-infected cells
|
DE3801236A1
(de)
|
1988-01-18 |
1989-07-27 |
Boehringer Mannheim Gmbh |
Pentosansulfat-medium
|
DE68925971T2
(de)
|
1988-09-23 |
1996-09-05 |
Cetus Oncology Corp |
Zellenzuchtmedium für erhöhtes zellenwachstum, zur erhöhung der langlebigkeit und expression der produkte
|
US6048728A
(en)
|
1988-09-23 |
2000-04-11 |
Chiron Corporation |
Cell culture medium for enhanced cell growth, culture longevity, and product expression
|
GB8823869D0
(en)
|
1988-10-12 |
1988-11-16 |
Medical Res Council |
Production of antibodies
|
WO1990005144A1
(en)
|
1988-11-11 |
1990-05-17 |
Medical Research Council |
Single domain ligands, receptors comprising said ligands, methods for their production, and use of said ligands and receptors
|
US5529920A
(en)
|
1988-12-14 |
1996-06-25 |
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Human liver epithelial cell line and culture media therefor
|
AU621972B2
(en)
|
1988-12-14 |
1992-03-26 |
United States of America, as represented by the Secretary, U.S. Department of Commerce, The |
Cell culture medium for human liver epithelial cell line
|
FR2646437B1
(fr)
|
1989-04-28 |
1991-08-30 |
Transgene Sa |
Nouvelles sequences d'adn, leur application en tant que sequence codant pour un peptide signal pour la secretion de proteines matures par des levures recombinantes, cassettes d'expression, levures transformees et procede de preparation de proteines correspondant
|
EP0402226A1
(en)
|
1989-06-06 |
1990-12-12 |
Institut National De La Recherche Agronomique |
Transformation vectors for yeast yarrowia
|
EP0479909B1
(en)
|
1989-06-29 |
1996-10-30 |
Medarex, Inc. |
Bispecific reagents for aids therapy
|
EP1132471A3
(de)
|
1989-09-12 |
2001-11-28 |
F. Hoffmann-La Roche Ag |
TNF-bindende Proteine
|
US5959177A
(en)
|
1989-10-27 |
1999-09-28 |
The Scripps Research Institute |
Transgenic plants expressing assembled secretory antibodies
|
JP2897043B2
(ja)
*
|
1989-12-21 |
1999-05-31 |
東ソー株式会社 |
完全合成培地
|
SG48759A1
(en)
|
1990-01-12 |
2002-07-23 |
Abgenix Inc |
Generation of xenogenic antibodies
|
JP3230091B2
(ja)
|
1990-06-25 |
2001-11-19 |
ウェルファイド株式会社 |
ヒト血清アルブミンの着色抑制方法
|
US5625126A
(en)
|
1990-08-29 |
1997-04-29 |
Genpharm International, Inc. |
Transgenic non-human animals for producing heterologous antibodies
|
KR100272077B1
(ko)
|
1990-08-29 |
2000-11-15 |
젠팜인터내셔날,인코포레이티드 |
이종 항체를 생산할 수 있는 전이유전자를 가진 인간이외의 동물
|
US5661016A
(en)
|
1990-08-29 |
1997-08-26 |
Genpharm International Inc. |
Transgenic non-human animals capable of producing heterologous antibodies of various isotypes
|
US5633425A
(en)
|
1990-08-29 |
1997-05-27 |
Genpharm International, Inc. |
Transgenic non-human animals capable of producing heterologous antibodies
|
US5545806A
(en)
|
1990-08-29 |
1996-08-13 |
Genpharm International, Inc. |
Ransgenic non-human animals for producing heterologous antibodies
|
US5122469A
(en)
|
1990-10-03 |
1992-06-16 |
Genentech, Inc. |
Method for culturing Chinese hamster ovary cells to improve production of recombinant proteins
|
EP0571390B1
(en)
|
1990-11-23 |
2000-03-08 |
Peptech Limited |
The delay, prevention and/or reversal of cell senescence
|
ATE164395T1
(de)
|
1990-12-03 |
1998-04-15 |
Genentech Inc |
Verfahren zur anreicherung von proteinvarianten mit geänderten bindungseigenschaften
|
US5571894A
(en)
|
1991-02-05 |
1996-11-05 |
Ciba-Geigy Corporation |
Recombinant antibodies specific for a growth factor receptor
|
CA2102511A1
(en)
|
1991-05-14 |
1992-11-15 |
Paul J. Higgins |
Heteroconjugate antibodies for treatment of hiv infection
|
EP0861893A3
(en)
|
1991-09-19 |
1999-11-10 |
Genentech, Inc. |
High level expression of immunoglobulin polypeptides
|
ATE181571T1
(de)
|
1991-09-23 |
1999-07-15 |
Medical Res Council |
Methoden zur herstellung humanisierter antikörper
|
US5587458A
(en)
|
1991-10-07 |
1996-12-24 |
Aronex Pharmaceuticals, Inc. |
Anti-erbB-2 antibodies, combinations thereof, and therapeutic and diagnostic uses thereof
|
WO1993008829A1
(en)
|
1991-11-04 |
1993-05-13 |
The Regents Of The University Of California |
Compositions that mediate killing of hiv-infected cells
|
US5667988A
(en)
|
1992-01-27 |
1997-09-16 |
The Scripps Research Institute |
Methods for producing antibody libraries using universal or randomized immunoglobulin light chains
|
DE69334255D1
(de)
|
1992-02-06 |
2009-02-12 |
Novartis Vaccines & Diagnostic |
Marker für Krebs und biosynthetisches Bindeprotein dafür
|
WO1993018143A1
(en)
|
1992-03-04 |
1993-09-16 |
Synaptic Pharmaceutical Corporation |
Dna encoding taurine and gaba transporters and uses thereof
|
JPH07102147B2
(ja)
|
1992-03-16 |
1995-11-08 |
株式会社ミドリ十字 |
ヒト血清アルブミンの着色抑制方法
|
WO1994004690A1
(en)
|
1992-08-17 |
1994-03-03 |
Genentech, Inc. |
Bispecific immunoadhesins
|
DE69329503T2
(de)
|
1992-11-13 |
2001-05-03 |
Idec Pharma Corp |
Therapeutische Verwendung von chimerischen und markierten Antikörpern, die gegen ein Differenzierung-Antigen gerichtet sind, dessen Expression auf menschliche B Lymphozyt beschränkt ist, für die Behandlung von B-Zell-Lymphoma
|
US5426699A
(en)
|
1993-10-25 |
1995-06-20 |
Antec Corporation |
Method and apparatus for digitizing a scrambled analog video signal
|
EP0666312A1
(en)
|
1994-02-08 |
1995-08-09 |
Wolfgang A. Renner |
Process for the improvement of mammalian cell growth
|
US5856179A
(en)
|
1994-03-10 |
1999-01-05 |
Genentech, Inc. |
Polypeptide production in animal cell culture
|
US5789199A
(en)
|
1994-11-03 |
1998-08-04 |
Genentech, Inc. |
Process for bacterial production of polypeptides
|
US5840523A
(en)
|
1995-03-01 |
1998-11-24 |
Genetech, Inc. |
Methods and compositions for secretion of heterologous polypeptides
|
US5731168A
(en)
|
1995-03-01 |
1998-03-24 |
Genentech, Inc. |
Method for making heteromultimeric polypeptides
|
US5641870A
(en)
|
1995-04-20 |
1997-06-24 |
Genentech, Inc. |
Low pH hydrophobic interaction chromatography for antibody purification
|
US5869046A
(en)
|
1995-04-14 |
1999-02-09 |
Genentech, Inc. |
Altered polypeptides with increased half-life
|
KR100654645B1
(ko)
|
1995-04-27 |
2007-04-04 |
아브게닉스, 인크. |
면역화된 제노마우스 유래의 인간 항체
|
CA2219486A1
(en)
|
1995-04-28 |
1996-10-31 |
Abgenix, Inc. |
Human antibodies derived from immunized xenomice
|
US5705364A
(en)
|
1995-06-06 |
1998-01-06 |
Genentech, Inc. |
Mammalian cell culture process
|
US6656466B1
(en)
|
1995-06-06 |
2003-12-02 |
Genetech, Inc. |
Human tumor necrosis factor—immunoglobulin(TNFR1-IgG1) chimera composition
|
CA2196802A1
(en)
|
1995-07-17 |
1997-02-06 |
Josef Wissler |
Metal-containing ribonucleotide polypeptides
|
US6267958B1
(en)
|
1995-07-27 |
2001-07-31 |
Genentech, Inc. |
Protein formulation
|
JP4306813B2
(ja)
|
1995-09-19 |
2009-08-05 |
アスビオファーマ株式会社 |
動物細胞の新規培養方法
|
US6043092A
(en)
|
1996-03-18 |
2000-03-28 |
University Of Pittsburgh |
Cell culture media for mammalian cells
|
US6146847A
(en)
*
|
1996-11-01 |
2000-11-14 |
Genespan Corporation |
Stabilized transient gene expression
|
KR20080059467A
(ko)
|
1996-12-03 |
2008-06-27 |
아브게닉스, 인크. |
복수의 vh 및 vk 부위를 함유하는 사람 면역글로불린유전자좌를 갖는 형질전환된 포유류 및 이로부터 생성된항체
|
US20080318254A9
(en)
|
1997-03-10 |
2008-12-25 |
The Regents Of The University Of California |
PSCA antibodies and hybridomas producing them
|
US20020012991A1
(en)
|
1997-04-07 |
2002-01-31 |
Florence Chua Nee Ho Kit Fong |
Cell culture media for enhanced protein production
|
US20020173629A1
(en)
|
1997-05-05 |
2002-11-21 |
Aya Jakobovits |
Human monoclonal antibodies to epidermal growth factor receptor
|
US6171586B1
(en)
|
1997-06-13 |
2001-01-09 |
Genentech, Inc. |
Antibody formulation
|
WO1998059035A2
(en)
|
1997-06-25 |
1998-12-30 |
The Goverment Of The United States Of America, Represented By The Secretary, Dept. Of Health And Human Services, National Institutes Of Health |
Serum-free cell growth medium
|
US6610833B1
(en)
|
1997-11-24 |
2003-08-26 |
The Institute For Human Genetics And Biochemistry |
Monoclonal human natural antibodies
|
WO1999035242A1
(en)
*
|
1998-01-12 |
1999-07-15 |
Betagene, Inc. |
Media for neuroendocrine cells
|
US6528286B1
(en)
|
1998-05-29 |
2003-03-04 |
Genentech, Inc. |
Mammalian cell culture process for producing glycoproteins
|
WO2000057891A1
(en)
|
1999-03-30 |
2000-10-05 |
Trustees Of Boston University |
Compositions and methods for producing platelets and/or proplatelets from megakaryocytes
|
DE60039596D1
(de)
|
1999-03-30 |
2008-09-04 |
Japan Tobacco Inc |
Verfahren zur herstellung von monoklonalen antikörpern
|
AT409379B
(de)
|
1999-06-02 |
2002-07-25 |
Baxter Ag |
Medium zur protein- und serumfreien kultivierung von zellen
|
US7087411B2
(en)
|
1999-06-08 |
2006-08-08 |
Regeneron Pharmaceuticals, Inc. |
Fusion protein capable of binding VEGF
|
CA2376379C
(en)
|
1999-06-08 |
2007-08-07 |
Regeneron Pharmaceuticals, Inc. |
Modified chimeric polypeptides with improved pharmacokinetic properties
|
CN1114619C
(zh)
|
1999-06-25 |
2003-07-16 |
中国科学院上海细胞生物学研究所 |
小鼠杂交瘤株Hepama-1分泌的肝癌鼠源单克隆抗体的制备方法
|
KR100797667B1
(ko)
|
1999-10-04 |
2008-01-23 |
메디카고 인코포레이티드 |
외래 유전자의 전사를 조절하는 방법
|
US7125978B1
(en)
|
1999-10-04 |
2006-10-24 |
Medicago Inc. |
Promoter for regulating expression of foreign genes
|
US7105348B2
(en)
|
2000-10-31 |
2006-09-12 |
Regeneron Pharmaceuticals, Inc. |
Methods of modifying eukaryotic cells
|
RU2192884C2
(ru)
|
2000-11-09 |
2002-11-20 |
Государственное учреждение Научно-исследовательский институт клинической иммунологии СО РАМН |
Вакцина для стимуляции противоопухолевого иммунитета
|
US7311905B2
(en)
|
2002-02-13 |
2007-12-25 |
Anthrogenesis Corporation |
Embryonic-like stem cells derived from post-partum mammalian placenta, and uses and methods of treatment using said cells
|
ATE325865T1
(de)
|
2001-01-16 |
2006-06-15 |
Regeneron Pharma |
Isolierung von sezernierte proteine exprimierenden zellen
|
US20090137416A1
(en)
|
2001-01-16 |
2009-05-28 |
Regeneron Pharmaceuticals, Inc. |
Isolating Cells Expressing Secreted Proteins
|
WO2002092017A2
(en)
|
2001-05-16 |
2002-11-21 |
Albert Einstein College Of Medicine Of Yeshiva University |
Human antipneumococcal antibodies from non-human animals
|
US20030087372A1
(en)
|
2001-06-13 |
2003-05-08 |
Genentech, Inc. |
Methods of culturing animal cells and polypeptide production in animal cells
|
US7153507B2
(en)
|
2001-08-23 |
2006-12-26 |
Genmab A/S |
Human antibodies specific for interleukin 15 (IL-15)
|
EP1321515A1
(en)
|
2001-12-21 |
2003-06-25 |
Ingenium Pharmaceuticals AG |
Method of culturing cells
|
CN1180080C
(zh)
|
2002-01-18 |
2004-12-15 |
中国科学院上海细胞生物学研究所 |
一种改进的肝癌鼠源单克隆抗体的制备方法
|
KR100562195B1
(ko)
|
2002-03-08 |
2006-03-20 |
에이에스엠엘 네델란즈 비.브이. |
리소그래피용 마스크, 마스크 제조방법, 리소그래피장치및 디바이스제조방법
|
US20030190710A1
(en)
*
|
2002-03-28 |
2003-10-09 |
Devries Ruth L. |
Control of glycoforms in IgG
|
US8673589B2
(en)
|
2002-05-29 |
2014-03-18 |
Regeneron Pharmaceuticals, Inc. |
Inducible eukaryotic expression system
|
MXPA04011679A
(es)
|
2002-05-29 |
2005-03-07 |
Regeneron Pharma |
Sistema de expresion eucariotico inducible.
|
US7371922B2
(en)
|
2002-07-31 |
2008-05-13 |
The Board Of Trustees Of The University Of Illinois |
Nuclear transfer with porcine embryonic stem cells
|
US6924124B1
(en)
|
2002-08-23 |
2005-08-02 |
Immunex Corporation |
Feeding strategies for cell culture
|
JP2007525410A
(ja)
|
2003-01-17 |
2007-09-06 |
ザ リサーチ ファンデーション オブ ステイト ユニバーシティ オブ ニューヨーク |
膵臓癌に関連する抗原、それらに対する抗体、及び診断方法及び処置方法
|
US7807458B2
(en)
|
2003-01-30 |
2010-10-05 |
The United States Of America As Represented By The Secretary Of The Department Of Veterans Affairs |
Multilineage-inducible cells and uses thereof
|
DK1623019T4
(en)
|
2003-05-15 |
2017-03-27 |
Wyeth Llc |
LIMITED GLUCOSE SUPPLY TO ANIMAL CELL CULTURE
|
WO2005023177A2
(en)
|
2003-05-21 |
2005-03-17 |
Medarex, Inc. |
Human monoclonal antibodies against bacillusanthracis protective antigen
|
US7303694B2
(en)
|
2003-07-17 |
2007-12-04 |
Wisconsin Alumni Research Foundation |
Liquid crystals with reduced toxicity and applications thereof
|
KR20060076781A
(ko)
|
2003-09-18 |
2006-07-04 |
레이븐 바이오테크놀로지스, 인코퍼레이티드 |
세포 배양 배지
|
JP4680997B2
(ja)
|
2004-06-08 |
2011-05-11 |
ツェンドゥー カンホン バイオテクノロジーズ カンパニー リミテッド |
血管新生を阻害するキメラタンパク質およびその利用
|
TWI384069B
(zh)
|
2004-08-27 |
2013-02-01 |
Pfizer Ireland Pharmaceuticals |
多胜肽之製法
|
JO3000B1
(ar)
|
2004-10-20 |
2016-09-05 |
Genentech Inc |
مركبات أجسام مضادة .
|
AU2005302516A1
(en)
*
|
2004-10-29 |
2006-05-11 |
Centocor, Inc. |
Chemically defined media compositions
|
US20060094104A1
(en)
|
2004-10-29 |
2006-05-04 |
Leopold Grillberger |
Animal protein-free media for cultivation of cells
|
US8273553B2
(en)
|
2004-11-02 |
2012-09-25 |
Ares Trading S.A. |
Production of growth hormone in serum-free cell culture medium for mammalian cells
|
CN101128486A
(zh)
|
2005-02-18 |
2008-02-20 |
米德列斯公司 |
缺乏岩藻糖残基的抗cd30单克隆抗体
|
JP2008536524A
(ja)
|
2005-04-21 |
2008-09-11 |
グレン エー. ゴールドスタイン, |
不妊に関連する酸化ストレス治療のためのn−アセチルシステインアミド(nacアミド)
|
EP1874350A2
(en)
|
2005-04-22 |
2008-01-09 |
Genentech, Inc. |
Method for treating dementia or alzheimer's disease with a cd20 antibody
|
AR058140A1
(es)
|
2005-10-24 |
2008-01-23 |
Wyeth Corp |
Metodo de produccion proteica utilizando compuestos anti-senescencia
|
CN101360820A
(zh)
|
2006-01-04 |
2009-02-04 |
巴克斯特国际公司 |
无寡肽的细胞培养基
|
DE602007008627D1
(de)
|
2006-02-14 |
2010-10-07 |
Genetix Ltd |
Zellkulturmedium
|
US8216575B2
(en)
|
2006-03-31 |
2012-07-10 |
Chengdu Kanghong Biotechnologies Co., Ltd. |
Inhibition of neovascularization with a soluble chimeric protein comprising VEGF FLT-1 and KDR domains
|
US7582298B2
(en)
|
2006-06-02 |
2009-09-01 |
Regeneron Pharmaceuticals, Inc. |
High affinity antibodies to human IL-6 receptor
|
ZA200810412B
(en)
|
2006-06-09 |
2010-03-31 |
Anthrogenesis Corp |
Placental niche and use thereof to culture stem cells
|
US7534595B2
(en)
*
|
2006-06-12 |
2009-05-19 |
Biomarin Pharmaceutical Inc. |
Compositions of prokaryotic phenylalanine ammonia-lyase and methods of using compositions thereof
|
US7608693B2
(en)
|
2006-10-02 |
2009-10-27 |
Regeneron Pharmaceuticals, Inc. |
High affinity human antibodies to human IL-4 receptor
|
ES2538986T3
(es)
|
2006-11-08 |
2015-06-25 |
Wyeth Llc |
Medios diseñados racionalmente para un cultivo celular
|
TW200902708A
(en)
|
2007-04-23 |
2009-01-16 |
Wyeth Corp |
Methods of protein production using anti-senescence compounds
|
WO2008151219A1
(en)
|
2007-06-04 |
2008-12-11 |
Regeneron Pharmaceuticals, Inc. |
Enhanced expression and stability regions
|
US20100221823A1
(en)
|
2007-06-11 |
2010-09-02 |
Amgen Inc. |
Method for culturing mammalian cells to improve recombinant protein production
|
PL2178916T3
(pl)
|
2007-07-31 |
2015-08-31 |
Regeneron Pharma |
Ludzkie przeciwciała przeciwko ludzkiemu CD20 i sposób ich zastosowania
|
US8697397B2
(en)
|
2007-08-07 |
2014-04-15 |
Chugai Seiyaku Kabushiki Kaisha |
Method of producing heterogeneous protein
|
US8309088B2
(en)
|
2007-08-10 |
2012-11-13 |
Regeneron Pharmaceuticals, Inc. |
Method of treating osteoarthritis with an antibody to NGF
|
CN100482786C
(zh)
|
2007-12-28 |
2009-04-29 |
天津百若克医药生物技术有限责任公司 |
一种人胚肾293细胞扩增无蛋白培养基
|
EP2250251B1
(en)
|
2008-01-09 |
2017-11-22 |
Sartorius Stedim Cellca GmbH |
Improved culture media additive and process for using it
|
JP2012503487A
(ja)
|
2008-09-26 |
2012-02-09 |
シェーリング コーポレイション |
高力価抗体の製造
|
JO3672B1
(ar)
|
2008-12-15 |
2020-08-27 |
Regeneron Pharma |
أجسام مضادة بشرية عالية التفاعل الكيماوي بالنسبة لإنزيم سبتيليسين كنفرتيز بروبروتين / كيكسين نوع 9 (pcsk9).
|
DK2438171T3
(en)
|
2009-06-02 |
2015-01-26 |
Regeneron Pharma |
Fucosylerings-deficient cells
|
CN101603026B
(zh)
|
2009-06-19 |
2011-01-19 |
华东理工大学 |
适于动物细胞产品生产的无动物来源低蛋白培养基
|
RU2522002C2
(ru)
|
2009-06-26 |
2014-07-10 |
Ридженерон Фармасьютикалз, Инк. |
Легковыделяемые биспецифические антитела с природным иммуноглобулиновым форматом
|
JP2012533548A
(ja)
|
2009-07-14 |
2012-12-27 |
バイオジェン・アイデック・エムエイ・インコーポレイテッド |
組成物における黄色形成および過酸化物形成を阻害する方法
|
BR112012002151B1
(pt)
|
2009-07-31 |
2021-07-06 |
Baxalta GmbH |
método para expressar uma desintegrina e metaloproteinase com proteína de motivo trombospondina (adamts)
|
EP3431588A1
(en)
|
2009-08-11 |
2019-01-23 |
F. Hoffmann-La Roche AG |
Production of proteins in glutamine-free cell culture media
|
WO2011079004A1
(en)
|
2009-12-23 |
2011-06-30 |
Schering Corporation |
Cell line 3m
|
JO3417B1
(ar)
|
2010-01-08 |
2019-10-20 |
Regeneron Pharma |
الصيغ المستقرة التي تحتوي على الأجسام المضادة لمضاد مستقبل( interleukin-6 (il-6r
|
JO3340B1
(ar)
|
2010-05-26 |
2019-03-13 |
Regeneron Pharma |
مضادات حيوية لـعامل تمايز النمو 8 البشري
|
EP2591094B1
(en)
|
2010-07-08 |
2018-09-05 |
Baxalta GmbH |
Method of producing recombinant adamts13 in cell culture
|
JOP20190250A1
(ar)
|
2010-07-14 |
2017-06-16 |
Regeneron Pharma |
صيغ مستقرة تحتوي على الأجسام المضادة لمضاد عامل نمو الأعصاب
|
EP2611904A2
(en)
|
2010-08-31 |
2013-07-10 |
Friesland Brands B.V. |
Culture medium for eukaryotic cells
|
AR083044A1
(es)
|
2010-09-27 |
2013-01-30 |
Regeneron Pharma |
Anticuerpos anti-cd48 y usos de los mismos
|
US8945559B2
(en)
|
2010-10-06 |
2015-02-03 |
Regeneron Pharmaceuticals, Inc. |
Stabilized formulations containing anti-interleukin-4 receptor (IL-4R) antibodies
|
JP2013542736A
(ja)
|
2010-11-05 |
2013-11-28 |
アッヴィ・インコーポレイテッド |
細胞培養における合成培地開発のための効率的および効果的な栄養補助剤のスクリーニング
|
JO3756B1
(ar)
|
2010-11-23 |
2021-01-31 |
Regeneron Pharma |
اجسام مضادة بشرية لمستقبلات الجلوكاجون
|
CN102093978A
(zh)
|
2010-12-17 |
2011-06-15 |
上海市农业科学院 |
猪早期胚胎发育前期培养液及后期培养液
|
SG191371A1
(en)
|
2010-12-28 |
2013-08-30 |
Chugai Pharmaceutical Co Ltd |
Animal cell culturing method
|
AR084754A1
(es)
|
2010-12-30 |
2013-06-05 |
Anthrogenesis Corp |
Composiciones que comprenden celulas madre de placenta y plasma rico en plaquetas, y sus metodos de uso
|
AR087329A1
(es)
|
2011-06-17 |
2014-03-19 |
Regeneron Pharma |
Anticuerpos humanos contra proteina 3 de tipo angiopoietina humana
|
US9364542B2
(en)
*
|
2011-10-28 |
2016-06-14 |
Excelse Bio, Inc. |
Protein formulations containing amino acids
|
PL2780368T3
(pl)
|
2011-11-14 |
2018-06-29 |
Regeneron Pharmaceuticals, Inc. |
Kompozycje i sposoby do zwiększania masy mięśni i siły mięśni poprzez swoiste antaganizowanie GDF8 i/lub aktywiny A
|
CN104169299B
(zh)
|
2012-01-23 |
2018-06-05 |
瑞泽恩制药公司 |
含抗Ang-2 抗体的稳定化制剂
|
WO2013120497A1
(en)
|
2012-02-15 |
2013-08-22 |
Curevac Gmbh |
Nucleic acid comprising or coding for a histone stem-loop and a poly(a) sequence or a polyadenylation signal for increasing the expression of an encoded therapeutic protein
|
JP6090735B2
(ja)
|
2012-03-02 |
2017-03-08 |
国立大学法人山口大学 |
消化器系がん幹細胞を培養するための無血清培地、及びそれを用いた消化器系がん幹細胞の増殖方法
|
WO2013158273A1
(en)
|
2012-04-20 |
2013-10-24 |
Abbvie Inc. |
Methods to modulate c-terminal lysine variant distribution
|
US9334319B2
(en)
|
2012-04-20 |
2016-05-10 |
Abbvie Inc. |
Low acidic species compositions
|
CA2875294C
(en)
|
2012-04-25 |
2021-06-08 |
Riken |
Cell preparation containing myocardium-committed cell
|
JO3820B1
(ar)
|
2012-05-03 |
2021-01-31 |
Regeneron Pharma |
أجسام مضادة بشرية لـ fel d1وطرق لاستخدامها
|
ES2688019T3
(es)
|
2012-06-05 |
2018-10-30 |
The Regents Of The University Of California |
Métodos y composiciones para la producción acelerada de células epiteliales pigmentadas retinianas a partir de células pluripotentes
|
CA2876473C
(en)
|
2012-06-21 |
2021-05-11 |
Baxter International Inc. |
Virus filtration of cell culture media
|
TW201843172A
(zh)
|
2012-06-25 |
2018-12-16 |
美商再生元醫藥公司 |
抗-egfr抗體及其用途
|
AU2013298521A1
(en)
|
2012-08-02 |
2015-02-26 |
Sanofi |
Article of manufacture comprising aflibercept or ziv-aflibercept
|
CA2881679C
(en)
|
2012-08-13 |
2021-01-26 |
Regeneron Pharmaceuticals, Inc. |
Anti-pcsk9 antibodies with ph-dependent binding characteristics
|
CN204634080U
(zh)
|
2012-08-20 |
2015-09-09 |
施雷德公司 |
将led光源与电浪涌隔离的***以及包括该***的光源
|
JOP20200236A1
(ar)
|
2012-09-21 |
2017-06-16 |
Regeneron Pharma |
الأجسام المضادة لمضاد cd3 وجزيئات ربط الأنتيجين ثنائية التحديد التي تربط cd3 وcd20 واستخداماتها
|
WO2014058025A1
(ja)
*
|
2012-10-10 |
2014-04-17 |
中外製薬株式会社 |
改変宿主細胞の樹立方法
|
JO3405B1
(ar)
|
2013-01-09 |
2019-10-20 |
Regeneron Pharma |
الأجسام المضادة لمضاد مستقبل عامل النمو المشتق من الصفائح الدموية - بيتا واستخداماتها
|
US9173380B2
(en)
|
2013-02-18 |
2015-11-03 |
Garmin Switzerland Gmbh |
Animal indicator apparatus
|
JO3532B1
(ar)
|
2013-03-13 |
2020-07-05 |
Regeneron Pharma |
الأجسام المضادة لمضاد انترلوكين-33 واستعمالاتها
|
US9217168B2
(en)
|
2013-03-14 |
2015-12-22 |
Momenta Pharmaceuticals, Inc. |
Methods of cell culture
|
TWI659968B
(zh)
|
2013-03-14 |
2019-05-21 |
再生元醫藥公司 |
針對呼吸道融合病毒f蛋白質的人類抗體及其使用方法
|
AR095196A1
(es)
|
2013-03-15 |
2015-09-30 |
Regeneron Pharma |
Medio de cultivo celular libre de suero
|
JP6404314B2
(ja)
|
2013-03-15 |
2018-10-10 |
リジェネロン・ファーマシューティカルズ・インコーポレイテッドRegeneron Pharmaceuticals, Inc. |
Il−33拮抗薬とその使用法
|
US20160237400A1
(en)
|
2013-03-15 |
2016-08-18 |
The Jackson Laboratory |
Isolation of non-embryonic stem cells and uses thereof
|
SG11201507367PA
(en)
*
|
2013-03-15 |
2015-10-29 |
Genentech Inc |
Cell culture compositions with antioxidants and methods for polypeptide production
|
CN105324487B
(zh)
|
2013-05-29 |
2020-01-17 |
豪夫迈·罗氏有限公司 |
唾液酸化的定量控制
|
JP6108170B2
(ja)
*
|
2013-07-30 |
2017-04-05 |
株式会社大阪ソーダ |
細胞培養用培地
|
TWI641620B
(zh)
|
2013-08-21 |
2018-11-21 |
再生元醫藥公司 |
抗-prlr抗體及其用途
|
CN110559435B
(zh)
|
2013-09-11 |
2023-10-20 |
伊戈尔生物药品股份有限公司 |
包含离子性液体的液体蛋白质制剂
|
US9181337B2
(en)
|
2013-10-18 |
2015-11-10 |
Abbvie, Inc. |
Modulated lysine variant species compositions and methods for producing and using the same
|
US9085618B2
(en)
|
2013-10-18 |
2015-07-21 |
Abbvie, Inc. |
Low acidic species compositions and methods for producing and using the same
|
EP3062814A1
(en)
*
|
2013-10-29 |
2016-09-07 |
Albumedix A/S |
Antibody composition
|
SG11201605640UA
(en)
|
2014-01-13 |
2016-08-30 |
Amgen Inc |
Regulating ornithine metabolism to manipulate the high mannose glycoform content of recombinant proteins
|
TWI681969B
(zh)
|
2014-01-23 |
2020-01-11 |
美商再生元醫藥公司 |
針對pd-1的人類抗體
|
TWI680138B
(zh)
|
2014-01-23 |
2019-12-21 |
美商再生元醫藥公司 |
抗pd-l1之人類抗體
|
CA2940685C
(en)
|
2014-03-11 |
2023-10-24 |
Regeneron Pharmaceuticals, Inc. |
Anti-egfrviii antibodies and uses thereof
|
TWI754319B
(zh)
|
2014-03-19 |
2022-02-01 |
美商再生元醫藥公司 |
用於腫瘤治療之方法及抗體組成物
|
WO2015171523A1
(en)
|
2014-05-05 |
2015-11-12 |
Regeneron Pharmaceuticals, Inc. |
Humanized c5 and c3 animals
|
JO3701B1
(ar)
|
2014-05-23 |
2021-01-31 |
Regeneron Pharma |
مضادات حيوية بشرية لمتلازمة الشرق الأوسط التنفسية - بروتين كورونا فيروس الشوكي
|
MA40021A
(fr)
|
2014-06-03 |
2015-12-10 |
Lupin Ltd |
Processus de culture cellulaire destiné à produire une protéine
|
SG11201701711VA
(en)
|
2014-09-16 |
2017-04-27 |
Regeneron Pharma |
Anti-glucagon antibodies and uses thereof
|
TWI710573B
(zh)
|
2015-01-26 |
2020-11-21 |
美商再生元醫藥公司 |
抗伊波拉病毒醣蛋白之人類抗體
|
EP3736326B1
(en)
|
2015-04-01 |
2023-05-10 |
Boehringer Ingelheim International GmbH |
Cell culture medium
|
TW202330904A
(zh)
*
|
2015-08-04 |
2023-08-01 |
美商再生元醫藥公司 |
補充牛磺酸之細胞培養基及用法
|
LT3353212T
(lt)
|
2015-09-23 |
2021-12-27 |
Regeneron Pharmaceuticals, Inc. |
Optimizuoti anti-cd3 bispecifiniai antikūnai ir jų naudojimas
|
KR101936049B1
(ko)
|
2015-10-15 |
2019-01-08 |
(주)알테오젠 |
IgG Fc 도메인을 가지는 융합 단백질의 생산방법
|
TWI734775B
(zh)
|
2016-04-26 |
2021-08-01 |
美商美國泰福生技股份有限公司 |
細胞培養基
|
KR20210084695A
(ko)
|
2017-07-06 |
2021-07-07 |
리제너론 파마슈티칼스 인코포레이티드 |
당단백질을 만들기 위한 세포 배양 과정
|